Page last updated: 2024-10-21

pk 11195 and Asthma

pk 11195 has been researched along with Asthma in 1 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research Excerpts

ExcerptRelevanceReference
"18FDG uptake was greater in COPD than in normal subjects, with no increase in asthmatics."1.32In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. ( Jones, HA; Marino, PS; Morrell, NW; Shakur, BH, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, HA1
Marino, PS1
Shakur, BH1
Morrell, NW1

Other Studies

1 other study available for pk 11195 and Asthma

ArticleYear
In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma.
    The European respiratory journal, 2003, Volume: 21, Issue:4

    Topics: Aged; Analysis of Variance; Asthma; Case-Control Studies; Cell Count; Female; Fluorodeoxyglucose F18

2003